163 related articles for article (PubMed ID: 28457923)
21. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.
Raphael I; Nalawade S; Eagar TN; Forsthuber TG
Cytokine; 2015 Jul; 74(1):5-17. PubMed ID: 25458968
[TBL] [Abstract][Full Text] [Related]
22. [Pathogenic Th cell subsets in chronic inflammatory diseases].
Kumagai J; Hirahara K; Nakayama T
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(2):114-23. PubMed ID: 27212597
[TBL] [Abstract][Full Text] [Related]
23. Novel anti-inflammatory interleukin-35 as an emerging target for antiatherosclerotic therapy.
Bobryshev YV; Sobenin IA; Orekhov AN; Chistiakov DA
Curr Pharm Des; 2015; 21(9):1147-51. PubMed ID: 25312725
[TBL] [Abstract][Full Text] [Related]
24. A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis.
van Dijk RA; Duinisveld AJ; Schaapherder AF; Mulder-Stapel A; Hamming JF; Kuiper J; de Boer OJ; van der Wal AC; Kolodgie FD; Virmani R; Lindeman JH
J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25814626
[TBL] [Abstract][Full Text] [Related]
25. The many faces of CD8+ T cells in atherosclerosis.
van Duijn J; Kuiper J; Slütter B
Curr Opin Lipidol; 2018 Oct; 29(5):411-416. PubMed ID: 30020198
[TBL] [Abstract][Full Text] [Related]
26. Platelets regulate CD4⁺ T-cell differentiation via multiple chemokines in humans.
Gerdes N; Zhu L; Ersoy M; Hermansson A; Hjemdahl P; Hu H; Hansson GK; Li N
Thromb Haemost; 2011 Aug; 106(2):353-62. PubMed ID: 21655676
[TBL] [Abstract][Full Text] [Related]
27. ApoB-Specific CD4
Marchini T; Hansen S; Wolf D
Cells; 2021 Feb; 10(2):. PubMed ID: 33669769
[TBL] [Abstract][Full Text] [Related]
28. Targeting T cells to treat atherosclerosis: odyssey from bench to bedside.
Bullenkamp J; Dinkla S; Kaski JC; Dumitriu IE
Eur Heart J Cardiovasc Pharmacother; 2016 Jul; 2(3):194-9. PubMed ID: 27418972
[TBL] [Abstract][Full Text] [Related]
29. Inflammation in atherosclerosis.
Taleb S
Arch Cardiovasc Dis; 2016 Dec; 109(12):708-715. PubMed ID: 27595467
[TBL] [Abstract][Full Text] [Related]
30. Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.
Chistiakov DA; Sobenin IA; Orekhov AN
Immunol Lett; 2013 Mar; 151(1-2):10-22. PubMed ID: 23411158
[TBL] [Abstract][Full Text] [Related]
31. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes.
Han SF; Liu P; Zhang W; Bu L; Shen M; Li H; Fan YH; Cheng K; Cheng HX; Li CX; Jia GL
Clin Immunol; 2007 Jul; 124(1):90-7. PubMed ID: 17512253
[TBL] [Abstract][Full Text] [Related]
32. Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response.
Fu SH; Lin MH; Yeh LT; Wang YL; Chien MW; Lin SH; Chang DM; Sytwu HK
Gut; 2015 May; 64(5):765-75. PubMed ID: 25011937
[TBL] [Abstract][Full Text] [Related]
33. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice.
Wang L; Gao S; Xu W; Zhao S; Zhou J; Wang N; Yuan Z
J Mol Cell Cardiol; 2014 Jul; 72():20-7. PubMed ID: 24530901
[TBL] [Abstract][Full Text] [Related]
34. Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events.
Zhang J; Hua G; Zhang X; Tong R; DU X; Li Z
Nephrology (Carlton); 2010 Feb; 15(1):33-41. PubMed ID: 20377769
[TBL] [Abstract][Full Text] [Related]
35. Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance.
Cheng X; Chen Y; Xie JJ; Yao R; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH; Cheng Y
J Mol Cell Cardiol; 2008 Aug; 45(2):168-75. PubMed ID: 18502445
[TBL] [Abstract][Full Text] [Related]
36. The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.
Ding YH; Qian LY; Pang J; Lin JY; Xu Q; Wang LH; Huang DS; Zou H
Oncotarget; 2017 Aug; 8(35):59915-59928. PubMed ID: 28938693
[TBL] [Abstract][Full Text] [Related]
37. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
McLaren JE; Michael DR; Ashlin TG; Ramji DP
Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of regulatory T cells on the initiation and regression of atherosclerosis.
Foks AC; Frodermann V; ter Borg M; Habets KL; Bot I; Zhao Y; van Eck M; van Berkel TJ; Kuiper J; van Puijvelde GH
Atherosclerosis; 2011 Sep; 218(1):53-60. PubMed ID: 21621777
[TBL] [Abstract][Full Text] [Related]
39. Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson's disease.
Chen Y; Qi B; Xu W; Ma B; Li L; Chen Q; Qian W; Liu X; Qu H
Mol Med Rep; 2015 Oct; 12(4):6105-11. PubMed ID: 26239429
[TBL] [Abstract][Full Text] [Related]
40. The inflammatory Th 17 subset in immunity against self and non-self antigens.
Jin D; Zhang L; Zheng J; Zhao Y
Autoimmunity; 2008 Mar; 41(2):154-62. PubMed ID: 18324485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
